Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05312671
Title Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

bladder small cell carcinoma

urinary bladder small cell neuroendocrine carcinoma


Atezolizumab + Carboplatin + Etoposide

Atezolizumab + Cisplatin + Etoposide

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.